Multivariate analysis revealed that UBE2C expression associated with poor patients’ outcome in term of BCSS (p = 0.013, HR = 1.60, 95% CI; 1.10–2.30), independent on other prognostic parameters including LVI, tumour size, ER and HER2 status (Table 3). This evidence concerns the gene ERBB2 and neoplasm.